5-year Agreement Strengthens Cerus’ Leadership Position in the U.S. Market and Will Expand Patient Access to INTERCEPT Platelets Supplying about 40 percent of the nation’s blood supply, the Red Cross ...

Cerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery Patients Trial met the primary efficacy ...

Cerus (NASDAQ:CERS) executives used a presentation and fireside chat at the TD Cowen Healthcare Conference to reiterate the ...

Cerus’ Notified Body, TÜV-SÜD, has completed the review of the clinical module for the CE Mark submission for INTERCEPT Red Blood Cells (RBCs) CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation ...

Presentations and abstracts showcase the broad applicability and expected benefits of the INTERCEPT Blood System for platelets, plasma, IFC, and red blood cells CONCORD, Calif.--(BUSINESS WIRE)-- ...

DRK Blood Donation Service Baden-Württemberg – Hessen Starts INITIATE Study to Evaluate Pathogen-Inactivated Platelet Concentrates Treated with Cerus’ INTERCEPT™ Blood System in Routine Clinical ...

CERS’ INTERCEPT platform (kits + illuminators) is scaling globally, with record 2025 results. They’ve also grown their ...

Cerus Corporation (Nasdaq: CERS) announced today that members of the Company's management are scheduled to present at the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026, at ...

Cerus Corporation (Nasdaq: CERS) today announced that Vivek Jayaraman, Cerus’ chief operating officer, will be promoted to president and chief executive officer, effective July 1, 2026. William “Obi” ...

(Reuters) - U.S. health regulators on Tuesday approved a device developed by Cerus Corp to reduce the risk of infections in blood plasma transmitted during transfusions, such as HIV, hepatitis and ...

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) is proud to announce its celebration of World Blood Donor Day 2024. In 2005, the World Health Assembly designated June 14 as World ...

To acquire marketing rights from Asian partner BioOne BioOne to get about 1.2 mln Cerus shares at $3.08/shr Cerus to relinquish equity interest in BioOne Aug 24 (Reuters) - Cerus Corp said it will ...